Through our vast network we help our corporate clients with their product strategy, in- and out-licensing efforts, including asset valuation, M&A scouting, complex due dilligence and dealmaking from the first contact until the successful transaction.
We provide input on regulatory matters as well as support in pricing and reimbursement decisions and communication with decision-making authorities
We guide products from the basic science all the way to their succesful commercialization or a spin-off.
Consulting on the technical capabilities and results of various types of COVID-19 tests, introduction of new non-COVID products to the portfolio, including the state-of-the-art technologies not previously present in the respective markets and a <1hr COVID-19 PCR test.
Established significant market traction on behalf of the company, in the SME as well as the public health sector for the (20+ F2F introductions, 5 qualified leads, 1 partnership).
Ongoing
Swedish start-up - Provided a framework for the market access strategy in the Austrian market.